About Hebei Petro China Center Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Hebei Petro China Center Hospital
During the past decade, Hebei Petro China Center Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
PREVAIL: PREvention of VTE After Acute Ischemic Stroke With LMWH Enoxaparin ( - VTE: Venous Thromboembolism - LMWH: Low Molecular Weight Heparin)
2003-08-01
Completed
Hexadecasaccharide (SR123781A) in Patients With Unstable Angina or Non-ST-Segment Elevation Myocardial Infarction
2004-12-01
2007-05-01
Completed
1,257
Opposing Step-by-step Insulin Reinforcement to Intensified Strategy
2004-12-01
Completed
811
MASCOT : Multicenter Asia Study in Adjuvant Treatment of Colon Cancer With OxaliplaTin/5FU-LV
2004-08-01
Completed
Study of Weight-Reducing Effect and Safety of Rimonabant In Obesity in ASIA (RIO-ASIA)
2006-04-01
2007-04-01
Completed
643
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Hebei Petro China Center Hospital
According to Clinical.Site data, the most researched conditions in "Hebei Petro China Center Hospital" are
"COVID-19" (2 trials), "Diabetic Peripheral Neuropathy (DPN)" (1 trials) and "Paresthesia" (1 trials). Many other conditions were trialed in "Hebei Petro China Center Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Hebei Petro China Center Hospital
Most popular intervention types in "Hebei Petro China Center Hospital" are "Biological" (2 trials) and "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "COVID-19 mRNA vaccine" (2 trials) and "Acetyllevocarnitine Hydrochloride Tablets" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hebei Petro China Center Hospital
The vast majority of trials in "Hebei Petro China Center Hospital" are
3 trials for "All" genders.
Clinical Trials Status at Hebei Petro China Center Hospital
Currently, there are NaN active trials in "Hebei Petro China Center Hospital".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Hebei Petro China Center Hospital,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hebei Petro China Center Hospital, 1 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".